{"id":1716,"date":"2024-01-10T10:02:18","date_gmt":"2024-01-10T09:02:18","guid":{"rendered":"https:\/\/www.sgd-pharma.com\/sgd-pharma-defines-2024-growth-strategy-as-it-strives-for-market-leadership-with-investment-achievements\/"},"modified":"2026-09-15T08:58:56","modified_gmt":"2026-09-15T07:58:56","slug":"sgd-pharma-defines-2024-growth-strategy-as-it-strives-for-market-leadership-with-investment-achievements","status":"publish","type":"post","link":"https:\/\/www.sgd-pharma.com\/en\/sgd-pharma-defines-2024-growth-strategy-as-it-strives-for-market-leadership-with-investment-achievements\/","title":{"rendered":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements"},"content":{"rendered":"<div class=\"trait-block max-w-3xl mx-auto px-4 mt-10 mb-3\">\n  <svg class=\"w-7 h-auto text-blue\" viewBox=\"0 0 28 7\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n  <path d=\"M27.4629 0C27.4629 3.75941 24.4153 6.80702 20.6559 6.80702L0.000976265 6.80702C0.000976429 3.04761 3.04858 -1.06718e-06 6.808 -9.02854e-07L27.4629 0Z\" fill=\"currentColor\"\/>\n<\/svg><\/div>\n\n\n<section class=\"pt-28 md:pt-32 pb-0 \">\n      <div class=\"container hidden md:block pb-8 md:pb-16\">\n      <nav class=\"breadcrumb uppercase [&#038;_a]:text-blue text-xs font-medium \" class=\"[&#038;_span]:flex [&#038;_span]:items-center\" aria-label=\"Breadcrumb\">\n    <div id=\"breadcrumbs\"><span><span><a href=\"https:\/\/www.sgd-pharma.com\/en\/\">Home<\/a><\/span><\/span><\/div>\n  <\/nav>\n    <\/div>\n    <div class=\"container max-w-4xl text-center md:mt-15\">\n          <span class=\"inline-block text-xs font-medium tracking-[0.25em] uppercase text-blackbody mb-2.5\">10 JANUARY 2024<\/span>\n    \n          <h1 class=\"text-[26px] leading-snug text-blackbody [&amp;_strong]:text-blue [&#038;_strong]:font-bold\">\n        SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements\n      <\/h1>\n    \n    \n  <\/div>\n\n      \n    <div class=\"mt-12 w-full overflow-hidden h-62 md:h-auto md:aspect-[1400\/526]\">\n                        <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"1200\" src=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png\" class=\"w-full h-full object-cover\" alt=\"\" srcset=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png 1200w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0-300x300.png 300w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0-1024x1024.png 1024w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0-150x150.png 150w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0-768x768.png 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/>\n                  <\/div>\n  \n<\/section>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span><span><span lang=\"EN-US\"><a href=\"https:\/\/www.sgd-pharma.com\/\">SGD Pharma,<\/a><\/span><span lang=\"EN-US\"> announces its goal to become the global market leader in primary pharmaceutical glass packaging. CEO Olivier Rousseau explains that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent approach to its commercial, innovation, industrial, sustainability, HR and M&amp;A strategies.<\/span><\/span><\/span><\/span><\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span><span><span lang=\"EN-US\">Underpinning this objective Rousseau outlines the investment achievements already notched up in 2023, to illustrate how SGD Pharma has paved the way for this planned growth: <\/span><span lang=\"EN-GB\">\u201cThe start of 2023 brought a new partnership, with the announcement of our joint venture with Corning, supported by investment from the Telangana state in India. This collaboration combined Corning\u2019s state-of-the-art coating technology with SGD Pharma\u2019s glass-converting expertise to manufacture Velocity Vials, Type I borosilicate glass tubing.\u201d The construction of a new tubing plant officially began with a celebratory ground-breaking ceremony at the plant in Vemula, India in June 2023. On completion, this new facility will expand pharmaceutical packaging manufacturing in India and access to the Corning Velocity Vial technology in the region.<\/span><\/span><\/span><\/span><\/span><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/photo-a-utiliser-1024x681.jpg\" alt=\"Corning JV\" class=\"wp-image-1712\"\/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>Another key area of progress for SGD Pharma last year was the company\u2019s sustainable efforts and decarbonization strategy. SGD Pharma was awarded a gold EcoVadis sustainability rating and made a number of modifications throughout the year to improve its high score for the 2023 award. EcoVadis assesses companies in four key areas \u2013 Environment, Labour and Human Rights, Sustainable Procurement and Ethics \u2013 rating a company relative to its peers. High scores across the board put SGD Pharma in the top 5% of glass product manufacturers, with particularly high scores for sustainable procurement.\u00a0 <\/span><\/span><\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>SGD Pharma released its 2023 CSR report in June, outlining the three pillars of its sustainability strategy: to become industry leader in decarbonization, (with planned reductions in emissions by -65% by 2040) as well as leadership in sustainable compliance and sustainable H&amp;S and HR practices.\u00a0 At the end of the year, SGD Pharma joined the Science Based Targets initiative (SBTi) as part of the company\u2019s sustainability drive. The SBTi is a global body enabling businesses to set ambitious targets for emissions reductions in line with leading climate science. SGD Pharma\u2019s plants in France, Germany, India and China plan to cut CO2 scope 1 and 2 emissions by 35% by 2030 and by 65% by 2040 (compared with a 2020 baseline). 100% of all SGD Pharma-owned glass manufacturing plants are ISO 45001 certified and that 79% of all waste is recycled.\u00a0 The company also received awards for its efforts towards decarbonization and mangrove advocacy at the CCI Event in Guangzhou, China.<\/span><\/span><\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>As well as the new line for Vemula, India, other site investments include the renovation of one of two furnaces at SGD Pharma\u2019s Saint Quentin Lamotte (SQLM) plant in France. This rebuild will contribute to a two-thirds reduction in the company\u2019s total carbon emissions by 2040 and will cut the SQLM CO2 emissions by almost 20%. Furthermore, a Memorandum of Understanding was signed with the Zhanjiang Mayor in China for SGD Pharma to invest in the rebuilding of the plant furnace at Zhanjiang and a new siliconization operation line will become operational at the SQLM plant to increase flexibility and capacity.<\/span><\/span><\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>In terms of products, SGD Pharma launched the extension of its Clareo range to include 10ml as well as its Sterinity range of ready-to-use vials in sizes 10ml and 20ml. The second half of the year saw the announcement of the company\u2019s pharmaceutical vial thermosealing offering, PROSEAL+. As many oral pharmaceutical products are sensitive to moisture and oxygen, PROSEAL+ provides a resistant hermetic seal that protects both the content and the user as the seal is also tamper evident.\u00a0\u00a0 <\/span><\/span><\/span><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"769\" src=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/sterinity-10ml-1024x769.jpg\" alt=\"Sterinity\" class=\"wp-image-1714\" srcset=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/sterinity-10ml-1024x769.jpg 1024w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/sterinity-10ml-300x225.jpg 300w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/sterinity-10ml-768x576.jpg 768w, https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/04\/sterinity-10ml.jpg 1195w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>Additionally, SGD Pharma celebrated 30 years in China at its Zhanjiang manufacturing plant, which produces molded glass and is market leader in glass for cosmetics and beauty packaging.\u00a0 Multiple product introductions for the eco cosmetics packaging market have been launched from China, where SGD Pharma is market leader in glass packaging for beauty.\u00a0 Eclipse, SGD Pharma\u2019s re-fillable jar and new mini fragrance samplers were showcased at Luxe Pack New York and its new NOVA lightweight glass bottle launched at Cosmoprof Asia.<\/span><\/span><\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span><span><span>To round up the investments in 2023, SGD Pharma CEO Olivier Rousseau is looking ahead to a number of strategic developments for 2024, which will start with announcements at Pharmapack 2024 on booth B60 &amp; B62.<\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1710,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[92],"tags":[],"class_list":["post-1716","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-beauty"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma\" \/>\n<meta property=\"og:description\" content=\"SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/\" \/>\n<meta property=\"og:site_name\" content=\"SGD Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-10T09:02:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-15T07:58:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"apsulis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"apsulis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/\"},\"author\":{\"name\":\"apsulis\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/#\\\/schema\\\/person\\\/8a62798b915dca88882a311e896833df\"},\"headline\":\"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements\",\"datePublished\":\"2024-01-10T09:02:18+00:00\",\"dateModified\":\"2026-09-15T07:58:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/\"},\"wordCount\":715,\"image\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/07\\\/news-1_0.png\",\"articleSection\":[\"Beauty\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/\",\"name\":\"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/07\\\/news-1_0.png\",\"datePublished\":\"2024-01-10T09:02:18+00:00\",\"dateModified\":\"2026-09-15T07:58:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/#\\\/schema\\\/person\\\/8a62798b915dca88882a311e896833df\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/07\\\/news-1_0.png\",\"contentUrl\":\"https:\\\/\\\/www.sgd-pharma.com\\\/app\\\/uploads\\\/2026\\\/07\\\/news-1_0.png\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/\",\"name\":\"SGD Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sgd-pharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sgd-pharma.com\\\/#\\\/schema\\\/person\\\/8a62798b915dca88882a311e896833df\",\"name\":\"apsulis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g\",\"caption\":\"apsulis\"},\"sameAs\":[\"https:\\\/\\\/www.sgd-pharma.com\\\/wp\"],\"url\":\"https:\\\/\\\/www.sgd-pharma.com\\\/en\\\/author\\\/apsulis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/","og_locale":"en_US","og_type":"article","og_title":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma","og_description":"SGD Pharma, announces its goal to become the global market leader in primary pharmaceutical glass&hellip;","og_url":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/","og_site_name":"SGD Pharma","article_published_time":"2024-01-10T09:02:18+00:00","article_modified_time":"2026-09-15T07:58:56+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png","type":"image\/png"}],"author":"apsulis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"apsulis","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#article","isPartOf":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/"},"author":{"name":"apsulis","@id":"https:\/\/www.sgd-pharma.com\/#\/schema\/person\/8a62798b915dca88882a311e896833df"},"headline":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements","datePublished":"2024-01-10T09:02:18+00:00","dateModified":"2026-09-15T07:58:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/"},"wordCount":715,"image":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png","articleSection":["Beauty"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/","url":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/","name":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements - SGD Pharma","isPartOf":{"@id":"https:\/\/www.sgd-pharma.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#primaryimage"},"image":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png","datePublished":"2024-01-10T09:02:18+00:00","dateModified":"2026-09-15T07:58:56+00:00","author":{"@id":"https:\/\/www.sgd-pharma.com\/#\/schema\/person\/8a62798b915dca88882a311e896833df"},"breadcrumb":{"@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#primaryimage","url":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png","contentUrl":"https:\/\/www.sgd-pharma.com\/app\/uploads\/2026\/07\/news-1_0.png","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.sgd-pharma.com\/sgd-pharma-definit-sa-strategie-de-croissance-2024-et-vise-le-leadership-du-marche-grace-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sgd-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"SGD Pharma defines 2024 growth strategy as it strives for market leadership with investment achievements"}]},{"@type":"WebSite","@id":"https:\/\/www.sgd-pharma.com\/#website","url":"https:\/\/www.sgd-pharma.com\/","name":"SGD Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sgd-pharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sgd-pharma.com\/#\/schema\/person\/8a62798b915dca88882a311e896833df","name":"apsulis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e6226aff737a0f86bf1da985e08e07921b82692b30397f978be25f559187e69e?s=96&d=mm&r=g","caption":"apsulis"},"sameAs":["https:\/\/www.sgd-pharma.com\/wp"],"url":"https:\/\/www.sgd-pharma.com\/en\/author\/apsulis\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1716"}],"version-history":[{"count":1,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1716\/revisions"}],"predecessor-version":[{"id":3726,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1716\/revisions\/3726"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/media\/1710"}],"wp:attachment":[{"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sgd-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}